Transferrin Receptors and Hematopoiesis: Review
|
|
- Gerald Craig
- 5 years ago
- Views:
Transcription
1 Institute of Experimental Morphology, Pathology and Anthropology with Museum Bulgarian Anatomical Society Acta morphologica et anthropologica, 23 Sofia 2016 Transferrin Receptors and Hematopoiesis: Review Y. Gluhcheva Institute of Experimental Morphology, Pathology and Anthropology with Museum BAS The effectiveness of hematopoiesis depends on hematopoietic cell activity as well as on the presence of iron. Iron uptake is regulated by some of the members of the transferrin family of iron-containing proteins transferrin and its receptors which assigns them a key regulatory role in hematopoiesis. Transferrins are expressed mainly in the liver, but small amounts arise also in the bone marrow, pancreas, testes, brain, spleen and kidneys. Experimental data show three types of transferrin receptors transferrin receptor 1 (TfR1), transferrin receptor 2 (TfR2) and soluble transferrin receptor (stfr). The expression of TfR1 and TfR2 is tissue- and cell cycle specific and is regulated by different control mechanisms, suggesting that they have different roles in iron metabolism. Cell surface TfR expression and concentration reflect iron requirements of the cells and they may be a useful marker for quantitative evaluation of the erythroid lineage, erythropoiesis and iron deficiency. Key words: transferrin, transferrin receptor 1 (TfR1), transferrin receptor 2 (TfR2), soluble transferrin receptor (stfr). Introduction Transferrin receptor is a cell membrane glycoprotein regulating cellular iron uptake by transferrin (Tf), a plasma protein which binds and transports iron [13]. Cell surface TfR concentration reflects iron requirements of the cell. Normally, about 60-70% of total body iron is incorporated in hemoglobin. Myoglobin, cytochromes and other iron-containing enzymes comprise 10% and the remaining 20-30% is stored in ferritin. Although iron bound to transferrin is less than 0.1% of the total body iron, it is the most important iron pool with the highest rate of turnover [13]. The transferrin binding site is situated on the extracellular domain of the receptor and each receptor subunit binds one transferrin molecule. Iron chelation by transferrin serves three main purposes: a) maintains Fe 3+ in a soluble form under physiologic conditions, b) facilitates regulated iron transport and cellular uptake, and c) maintains Fe 3+ in a redox-inert state, preventing the generation of toxic free radicals. Tf has an indirect defensive role against systemic infections by depriving the potential pathogens of extracellular iron, which is essential for their growth [4]. Under normal conditions, approximately 30% of the Tf iron-binding sites are saturated. In humans, values of Tf saturation <15% indicate iron deficiency, whereas >45% are consistent with iron overload [4]. 140
2 According to the scientific data there are three types of transferrin receptors transferrin receptor 1 (TfR1), transferrin receptor 2 (TfR2), and soluble transferrin receptor (stfr). 1.Transferrin receptor 1 (TfR1) Transferrin receptor (TfR) also known as CD71 is ubiquitously expressed at low levels on normal cells and at greater levels on cells with a high proliferation rate such as cells of the basal epidermis, intestinal epithelium, activated peripheral blood mononuclear cells, on cells that require large amounts of iron such as placental trophoblasts and maturing erythroid cells that require iron for heme synthesis. Mature erythroid cells do not express TfR. TfR expression has also been observed on nonproliferating cells such as the vascular endothelium of the brain capillaries, endocrine pancreas, seminiferous tubules of the testes, cells of the pituitary gland, luminal membranes of the breast, hepatocytes, Kupffer cells in the liver and tubules of the kidney [2, 5, 7]. Elevated levels of expression of the TfR are reported on cancer cells when compared to the normal cells [2]. Liu et al. demonstrate that during cell development from myeloid dysplasia to apparent leukemic cells, both CD71 and CD34 gradually increase and suggest that these molecules may be useful tools for understanding clonal development in leukemia [9]. According to Marsee et al. CD71 is a highly effective marker for the detection of cells of the erythroid lineage in bone marrow biopsy specimens as its immunoreactivity is restricted to erythroid precursors and exhibits a membranous and cytoplasmic staining pattern [10]. In humans, the TfR1 gene is located on human chromosome 3q29. TfR1 is the primary target of transferrin in the iron transport system and is expressed as a type II transmembrane glycoprotein composed of a disulfide-bonded homodimer on the surface of nearly every cell type. Each monomer (760 amino acids, molecular weight kda) contains a large extracellular C-terminal domain (671 amino acids) known as the ectodomain that contains the Tf-binding site, a single-pass transmembrane domain (28 amino acids), and a short intracellular N-terminal domain (61 amino acids). The ectodomain contains 3 N-linked glycosylation sites and one O-linked glycosylation site. Glycosylation at these sites is required for adequate function of the receptor [2]. TfR expression is primarily regulated at the post-transcriptional level in response to intracellular iron levels. The 3 untranslated region of the TfR transcript is large and plays an important role in the regulation of mrna stability. This region contains 5 iron response elements (IRE) that consist of approximately 30 nucleotides each that form loop structures and are involved in the post-transcriptional regulation of TfR expression. These IRE are recognized by two RNA-binding iron regulatory proteins (IRP) [2]. Once Tf binds to the extracellular domain of the TfR on the plasma membrane, it changes its conformation and dimerizes. The Tf-TfR complex enters the endocytic pathway via endocytosis mediated by clathrincoated pits and is transported to early endosomes. TfR1-mediated endocytosis is the only route for iron delivery to erythroid precursors [4]. Ablation of the TfR1 gene impairs erythropoiesis and neurologic development in mice and leads to embryonic lethality [8]. The Tf/TfR1 route is also essential for iron transport to the central nervous system (CNS) which is separated from the circulation by the blood brain barrier [4]. Astrocytes play a crucial role in providing iron to neurons, exporting the metal via ferroportin. Exported iron can bind to brain Tf, which is locally produced by the choroid plexus. Brain Tf delivers iron to TfR1-expressing cells, such as developing oligodendrocytes and neurons [4]. 2.Transferrin receptor 2 (TfR2) Transferrin receptor 2 (TfR2) is a 105 kda type II transmembrane glycoprotein, member of the TfR family and homologous to TfR1. The TfR2 s extracellular domain is 141
3 approximately 45% identical and 66% similar to the TfR1 ectodomain [2]. TfR2 binds to Tf with a 25-fold lower affinity and cannot substitute for TfR1, even though it is expressed in the erythroid compartment [12]. The gene for human TfR2 is located on human chromosome 7q22 [7]. The expression of TfR2 is restricted to hepatocytes, enterocytes of the small intestine and erythroid precursors and is not regulated by iron regulatory proteins (IRP) [2, 16]. Surface expression of TfR2 was also found on a wide variety of human cell lines derived from solid tumors and selected B and myeloid cell lines [2]. Expression of TfR2 increased in the liver during embryo development, whereas expression of TfR1 decreased. In the spleen, expression of TfR1 increased while the levels of TfR2 were constant during development [6]. Low expression of TfR transcripts was also found in lungs, testis, heart, duodenum, brain and kidneys [6]. In human bone marrow TfR2 protein staining was detected on erythroblasts but not on more differentiated erythroid cells. There was also staining on megakaryocytes, but not myeloid cells [6]. Forejtnikova et al. show that TfR2 and the receptor for erythropoietin (EpoR) are synchronously coexpressed during the differentiation of erythroid progenitors. TfR2 associates with EpoR in the endoplasmic reticulum and is required for the efficient transport of this receptor to the cell surface. Erythroid progenitors from TfR2-/- knockout mice show a decreased sensitivity to Epo and increased circulating levels of erythropoietin (Epo) [3]. According to Nai et al. by modulating the Epo sensitivity of the erythroid precursors, TfR2 may act as a control system of red blood cells count to maintain a correct balance between their production and the available iron [11]. Erythroid TfR2 restricts Epo sensitivity to limit excessive erythropoiesis [12]. Wallace et al. suggest a possible regulatory role of TfR2 in Epo production by the kidney [18]. TfR2 and TfR1 differ in their expression during erythroid differentiation. TfR2 was reduced while TfR1 levels increased with differentiation in MEL cells and in human erythroid cells having the highest TfR2 expression in erythroblasts [6]. TfR2 mrna expression is cell cycle dependent. In MG63 osteosarcoma cells, there was no expression in the G 0 /G 1 phase and expression reached its highest level in the late G 1 phase, with a lower level of expression continuing through the remaining stages of the cell cycle. In contrast, TfR1 expression peaked at both late G 1 and G 2 /M stages [17]. Inactivation of TfR2 leads to the development of hemochromatosis due to inappropriate hepcidin levels relative to body iron [14]. The authors show in a model of anemic mice that the absence of hematopoietic TfR2 delays erythroid differentiation and immature polychromatic erythroblasts accumulate in the spleen and bone marrow of anemic mice. The results demonstrate that erythroid TfR2 is essential for an appropriate erythropoietic response in iron-deficient anemia [14]. Along with hemojuvelin and HFE, TfR2 is regarded as an upstream regulator of of iron signaling to hepcidin [12]. TfR2 is stabilized in response to high Tf saturation. Hepatic TfR2 promotes iron signaling to hepcidin to inhibit further iron fluxes to the bloodstream. Experimental data reveal that mice lacking TMPRSS6 and TfR2 have splenomegaly and extramedullary hematopoiesis in the spleen [18]. The authors observe altered red-white pulp architecture, infiltration of red pulp with nucleated red cells and variable megakaryocyte infiltration. Flow cytometric analysis revealed increased proportions of cells in the immature erythroblast subpopulations I, II and III compared to wild type (control) mice and reduction in subpopulation IV, corresponding to mature erythrocytes, suggesting that TfR2 is required for terminal erythroblast differentiation [18]. Rishi et al. demonstrate that mice with similar knockout alleles fed an iron deficient diet significantly accumulated nucleated erythroid cells in their liver. The authors also show a significantly increased extramedullary hematopoiesis in the liver and spleen as compared to the control mice on the same diet [14]. The results suggest a key regulatory role of TfR2 in erythropoiesis. 142
4 3. Soluble transferrin receptor (stfr) TfRs are also present in the circulation and the circulating serum TfR (stfr) level reflects total body TfR concentration [15]. Under normal conditions erythroid precursors the erythroblasts are the main source of stfr. Serum stfr levels average 5.0 ± 1.0 mg/l in normal subjects. The most important determinant of stfr levels is the bone marrow erythropoietic activity which can cause variations up to 8 times below and up to 20 times above average normal values [1]. Disorders of the bone marrow with reduced erythroid precursors are associated with low stfr levels. The stfr concentration begins to rise early in iron deficiency with the onset of iron-deficient erythropoiesis. It is also increased in patients with expanded erythropoiesis, including hemolytic anemias, myelodysplastic syndromes and use of erythropoietic stimulating agents [15]. stfr level is decreased in cases of decreased erythropoiesis, bone marrow ablation with stem cell transplantation, aplastic anemia, pure red cell aplasia, etc. [15]. Measurements of stfr are very helpful to investigate the pathophysiology of anemia, quantitatively evaluating the absolute rate of erythropoiesis and the adequacy of bone marrow proliferative capacity for any degree of anemia and to monitor the erythropoietic response to various forms of therapy, in particular allowing to predict response early when changes in hemoglobin are not yet apparent. With the exception of chronic lymphocytic leukemia (CLL) and high-grade non-hodgkin s lymphoma and possibly hepatocellular carcinoma, stfr levels are not increased in patients with malignancies [1]. Hematopoiesis depends on bone marrow hematopoietic cells proliferative activity as well as on the effectiveness of iron uptake. Iron uptake is regulated by transferrin which binds to a transferrin receptor. Alterations in this receptor impair erythropoiesis and development in mice. In light of the current experimental data one can say that despite of the high homology between TfR1 and TfR2, both receptors exhibit tissue and cell cycle specific expression and regulate hematopoiesis, each in a different way. Ablation in one of the receptors cannot be compensated by the other which suggests that each one regulates the process in a unique way. TfR expression and cell surface concentration may be a useful marker for quantitative evaluation of the erythroid lineage, inefficient erythropoiesis and iron deficiency. Measurement of serum TfR will allow adequate evaluation of erythropoiesis, body iron demands as well the response to therapy in cases of hematological disorders. R e f e r e n c e s 1. Beguin, Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin. Chim. Acta, 329, 2003, Daniels, T. R., T. Delgado, J. A. Rodriguez, G. Helguera, M. L. Penichet. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol., 121, 2006, Forejtnikova, H., M. Vieillevoye, Y. Zermati, M. Lambert, R. M. Pellegrino, S. Guihard, M. Gaudry, C. Camaschella, C. Lacombe, A. Roetto, P. Mayeux, F. Verdier. Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. Blood, 116, 2010, Gkouvatsos, K., G. Papanikolaou, K. Pantopoulos. Regulation of iron transport and the role of transferrin. Biochimica et Biophysica Acta, 1820, 2012, Harms, K., T. Kaiser. Beyond soluble transferrin receptor: old challenges and new horizons. Best Pract. Res. Clin. Endocrinol. Metab., 29, 2015, Kawabata, H., R. S. Germain, T. Ikezoe, X. Tong, E. M. Green, A. F. Gombart, H. P. Koeffler. Regulation of expression of murine transferrin receptor 2. Blood, 98, 2001,
5 7. Lambert, L. Molecular evolution of the transferrin family and associated receptors. Biochimica et Biophysica Acta, 1820, 2012, Levy, J. E., O. Jin, Y. Fujiwara, F. Kuo, N. C. Andrews. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet., 21, 1999, Liu, Q., M. Wang, Y. Hu, H. Xing, X. Chen, Y. Zhang, P. Zhu. Significance of CD71 expression by flow cytometry in diagnosis of acute leukemia. Leuk. Lymphoma, 55, 2014, Marsee, D. K., G. S. Pinkus, H. Yu. CD71 (Transferrin Receptor). An effective marker for erythroid precursors in bone marrow biopsy specimens. Am. J. Clin. Pathol., 134, 2010, Nai, A., M. R. Lidonnici, M. Rausa, G. Mandelli, A. Pagani, L. Silvestri, G. Ferrari, C. Camaschella. The second transferrin receptor regulates red blood cell production. Blood, 125, 2015, Pantopoulos, K. TfR2 links iron metabolism and erythropoiesis. Blood, 125, 2015, Ponka, P., C. N. Lok. The transferrin receptor: role in health and disease. Int. J. Biochem. Cell. Biol., 31, 1999, Rishi, G., E. S. Secondes, D. F. Wallace, V. N. Subramaniam. Hematopoietic deletion of transferrin receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia. Am. J. Hematol., 91, 2016, Skikne, B. Serum transferrin receptor. Am. J. Hematol., 83, 2008, Silvestri, L., A. Nai, A. Pagani, C. Camaschella. The extrahepatic role of TfR2 in iron homeostasis. Front. Pharmacol., 5, 2014, Trinder, D., E. Baker. Transferrin receptor 2: a new molecule in iron metabolism. Int. J. Biochem. Cell. Biol., 35, 2003, Wallace, D. F., E. S. Secondes, G. Rishi, L. Ostini, C. J. McDonald, S. W. Lane, T. Vu, J. D. Hooper, G. Velasco, A. J. Ramsay, C. Lopez-Otin, V. N. Subramaniam. A critical role for murine transferrin receptor 2 in erythropoiesis during iron restriction. Br. J. Haematol., 168, 2015,
Iron: a global issue in hematology. Clara Camaschella, MD
Iron: a global issue in hematology Clara Camaschella, MD Università Vita Salute San Raffaele e IRCCS San Raffaele - Milano Firenze, 18-19 settembre 2015 Clara Camaschella I have nothing to disclose Iron
More informationIntroduction 5/2/2013 IRON RELATED GENES AND OXIDATIVE STRESS IN NON- ALCOHOLIC STEATOHEPATITIS. Iron Physiology. Iron Physiology
// IRON RELATED GENES AND OXIDATIVE STRESS IN NON- ALCOHOLIC STEATOHEPATITIS DIANA MOYA, MD PEDIATRIC GASTROENTEROLOGY FELLOW DIGESTIVE DISEASES & NUTRITION CENTER MAY,. Iron Physiology. /NAFLD. Iron Metabolism
More informationFaculty of Medicine Dr. Tariq Aladily
Iron deficiency anemia The most common anemia worldwide Only 10% of ingested iron is absorbed Most dietary iron occurs in meat products Absorbed in duodenum Hepcidin By inhibiting ferroportin, hepcidin
More informationRecent Advances in Erythroid Iron Homeostasis: Implications for Pathophysiology of Microcytic Anemias
Recent Advances in Erythroid Iron Homeostasis: Implications for Pathophysiology of Microcytic Anemias Prem Ponka Department of Physiology Lady Davis Institute, Jewish General Hospital McGill University,
More informationHematology Unit Lab 2 Review Material
Objectives Hematology Unit Lab 2 Review Material - 2018 Laboratory Instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided
More informationYEAR III Pharm.D Dr. V. Chitra
YEAR III Pharm.D Dr. V. Chitra Anemia can be defined as a reduction in the hemoglobin,hematocrit or red cell number. In physiologic terms an anemia is any disorder in which the patient suffers from tissue
More informationFourth European Symposium on Rare Anaemias. Vita-Salute University - San Raffaele Scientific Institute, Milano
Fourth European Symposium on Rare Anaemias Clara Camaschella Vita-Salute University - San Raffaele Scientific Institute, Milano Sofia, Bulgaria, November 19-20, 2011 The iron cycle Hepcidin (Jordan et
More informationThioredoxin-interacting (TXNIP) protein regulates the differentiation of erythroid precursors
Thioredoxin-interacting (TXNIP) protein regulates the differentiation of erythroid precursors Volker Blank Lady Davis Institute for Medical Research McGill University www.scientificimages.co.uk INSTITUT
More informationAssessing Iron Deficiency in Adults. Chris Theberge. Iron (Fe) deficiency remains as one of the major global public health problems for
Assessing Iron Deficiency in Adults Chris Theberge Iron (Fe) deficiency remains as one of the major global public health problems for two reasons. It affects about one fourth of the world s population
More informationDiscovery. Hepcidin Today. Hepcidin: discovery June 2000: Man: Plasma ultrafiltrate Liver Expressed Antimicrobial Peptide
Hepcidin Today Rachel van Swelm 10 05 2018 ISLH www.radboud ironcenter.com; www.hepcidinanalysis.com Discovery Hepcidin: discovery June 2000: Man: Plasma ultrafiltrate Liver Expressed Antimicrobial Peptide
More informationAssociations Between Serum Transferrin Receptor Concentrations and Erythropoietic Activities According to Body Iron Status
Annals of Clinical & Laboratory Science, vol. 33, no. 3, 2003 279 Associations Between Serum Transferrin Receptor Concentrations and Erythropoietic Activities According to Body Iron Status Jong Weon Choi
More informationPathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16
35 Pathology #11 Acute Leukemias Farah Banyhany Dr. Sohaib Al- Khatib 23/2/16 1 Salam First of all, this tafreegh is NOT as long as you may think. If you just focus while studying this, everything will
More informationHemosiderin. Livia Vida 2018
Hemosiderin Livia Vida 2018 Questions Histochemical caracteristics of the different pigments. Exogenous pigments. Hemoglobinogenic pigments. Causes and forms of jaundice. Hemoglobinogenic pigments. Pathological
More informationAn update on hypoxic regulation of iron homeostasis and bone marrow environment
International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Review Article Volume 4, Issue 10-2018 DOI: http://dx.doi.org/10.22192/ijcrms.2018.04.10.007
More informationBlood & Blood Formation
Module IB Blood & Blood Formation Histology and Embryology Martin Špaček, MD (m.spacek@centrum.cz) http://www.lf3.cuni.cz/histologie Approximately 7% of a person's weight is blood (about 5 L) Blood consists
More informationMetabolismo del ferro in condizioni normali e patologiche
Metabolismo del ferro in condizioni normali e patologiche Clara Camaschella Università Vita-Salute e IRCCS San Raffaele, Milano Simposio SIES 41 Congresso Nazionale SIE - Bologna 14-17 ottobre 2007 Metabolismo
More informationBiochimica et Biophysica Acta
Biochimica et Biophysica Acta 1823 (2012) 1434 1443 Contents lists available at SciVerse ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbamcr Review Hepcidin and
More informationMYELODYSPLASTIC SYNDROMES
MYELODYSPLASTIC SYNDROMES Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra university hospital, Isfahan university of medical sciences Key Features ESSENTIALS OF DIAGNOSIS Cytopenias
More informationMetabolic Liver Diseases
Metabolic Liver Diseases Howard J. Worman, M. D. Department of Medicine Columbia University College of Physicians and Surgeons Three Classical Inherited Disorders of Metabolism Affecting the Liver Hereditary
More informationIntroduction and II. Blood Cells A. Introduction
Chapter 14: Blood 1. Blood is three to four times more viscous than water. Introduction and II. Blood Cells A. Introduction 2. Most blood cells form in red bone marrow. 3. Types of blood cells are red
More informationMOLECULAR MECHANISMS OF IRON UPTAKE BY HEPG2 HEPATOMA CELLS
MOLECULAR MECHANISMS OF IRON UPTAKE BY HEPG2 HEPATOMA CELLS By LIN ZHANG A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE
More informationBiol220 Cellular Signalling. Non-receptor tyrosine kinases
Biol220 Cellular Signalling Non-receptor tyrosine kinases The 7TM receptors initiate signal transducton pathways through changes in tertiary structure that are induced by ligand binding. A fundamentally
More informationAround million aged erythrocytes/hour are broken down.
Anemia Degradation ofheme Around 100 200 million aged erythrocytes/hour are broken down. The degradation process starts in reticuloendothelial cells in the spleen, liver, and bone marrow. [1] The tetrapyrrole
More informationMicrocytic Hypochromic Anemia An Approach to Diagnosis
Microcytic Hypochromic Anemia An Approach to Diagnosis Decreased hemoglobin synthesis gives rise to microcytic hypochromic anemias. Hypochromic anemias are characterized by normal cellular proliferation
More informationTopics of this lecture : RBC. Structural characteristics Hemoglobin Erythropoiesis Erythrocytes destruction
Topics of this lecture : RBC Structural characteristics Hemoglobin Erythropoiesis Erythrocytes destruction Structural characteristics Its small size and biconcave shape provides more surface area than
More informationIron age: novel targets for iron overload
IRON HOMEOSTASIS &CHRONIC DISEASE:DISORDERS OF IRON OVERLOAD Iron age: novel targets for iron overload Carla Casu 1 and Stefano Rivella 1,2 1 Department of Pediatrics, Division of Hematology-Oncology,
More informationTHE ROLE OF HEMOJUVELIN IN IRON DEFICIENCY AND OVERLOAD
THE ROLE OF HEMOJUVELIN IN IRON DEFICIENCY AND OVERLOAD Clara Camaschella Vita-Salute University and San Raffaele Scientific Institute Milan, Italy EHA ESH joint Workshop Cascais, Portugal, April 16-18,
More information2011 ASH Annual Meeting Targeting the Hepcidin Pathway with RNAi Therapeutics for the Treatment of Anemia. December 12, 2011
211 ASH Annual Meeting Targeting the Hepcidin Pathway with RNAi Therapeutics for the Treatment of Anemia December 12, 211 Hepcidin is Central Regulator of Iron Homeostasis Hepcidin is liver-expressed,
More informationInto the matrix: regulation of the iron regulatory hormone hepcidin by matriptase-2
Emerging Science Into the matrix: regulation of the iron regulatory hormone hepcidin by matriptase-2 Mitchell D Knutson Matriptase-2 is a recently identified membrane-bound, cell-surface serine protease
More informationSUPPLEMENTARY INFORMATION GENOTOXICITY. In vitro Genotoxicity Studies
SUPPLEMENTARY INFORMATION GENOTOXICITY In vitro Genotoxicity Studies The in vitro immortalisation (IVIM) assay relies on the induction of a survival advantage by insertional activation of cellular proto-oncogenes,
More informationThe hemoglobin (Hb) can bind a maximum of 220 ml O2 per liter.
Hemoglobin Hemoglobin The most important function of the red blood cells is totransport (O2) from the lungs into the tissues, and carbon dioxide (CO2) from the tissues back into the lungs. O2 is poorly
More information12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization
Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,
More informationClinical Aspects and Laboratory Iron Metabolism, Anemias
W Manfred Wick Wulf Pinggera Paul Lehmann Clinical Aspects and Laboratory Iron Metabolism, Anemias Concepts in the anemias of malignancies and renal and rheumatoid diseases Sixth, revised and updated
More informationMeeting Report. From December 8 to 11, 2012 at Atlanta, GA, U.S.A
Meeting Report Affiliation Department of Transfusion Medicine and Cell Therapy Name Hisayuki Yao Name of the meeting Period and venue Type of your presentation Title of your presentation The 54 th Annual
More informationNovità nelle MDS. Matteo G Della Porta. Cancer Center IRCCS Humanitas Research Hospital & Humanitas University Rozzano Milano, Italy
Novità nelle MDS Matteo G Della Porta Cancer Center IRCCS Humanitas Research Hospital & Humanitas University Rozzano Milano, Italy matteo.della_porta@hunimed.eu Outline ARCH Predictive value of somatic
More informationProduction of the Formed Elements (Chapter 11) *
OpenStax-CNX module: m62120 1 Production of the Formed Elements (Chapter 11) * Ildar Yakhin Based on Production of the Formed Elements by OpenStax This work is produced by OpenStax-CNX and licensed under
More informationMyeloproliferative Disorders - D Savage - 9 Jan 2002
Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2
More informationThe relationship between systemic iron homeostasis and erythropoiesis
Editorial The relationship between systemic iron homeostasis and erythropoiesis Gautam Rishi and V. Nathan Subramaniam The Liver Disease and Iron Disorders Research Group, Institute of Health and Biomedical
More informationZahraa Muneer. Enas Ajarma. Saleem
2 Zahraa Muneer Enas Ajarma Saleem Blood parameters: 1. RBCs count 2. Haematocrit 3. Haemoglobin content In new-born babies all three parameters of blood are higher than in normal adults. This happens
More informationDrugs Used in Anemia
Drugs Used in Anemia Drugs of Anemia Anemia is defined as a below-normal plasma hemoglobin concentration resulting from: a decreased number of circulating red blood cells or an abnormally low total hemoglobin
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423
More informationCHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009
LEUKEMIA CHAPTER:4 1 BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of
More informationDisease Pathogenesis and Research Progression of Renal Anemia
2018 3rd International Conference on Life Sciences, Medicine, and Health (ICLSMH 2018) Disease Pathogenesis and Research Progression of Renal Anemia Yingying Liu, Qi Jiang* Department of Nephrology, China-Japan
More informationJuvenile Myelomonocytic Leukemia (JMML)
Juvenile Myelomonocytic Leukemia (JMML) JMML: Definition Monoclonal hematopoietic disorder of childhood characterized by proliferation of the granulocytic and monocytic lineages Erythroid and megakaryocytic
More informationIron and hepcidin: a story of recycling and balance
HAM-WASSERMAN MANUSCRIPT Iron and hepcidin: a story of recycling and balance Clara Camaschella 1 1 Vita-Salute University and San Raffaele Scientific Institute, Milan, Italy To avoid iron deficiency and
More informationMyelodysplastic syndrome (MDS) & Myeloproliferative neoplasms
Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms Myelodysplastic syndrome (MDS) A multipotent stem cell that can differentiate into any of the myeloid lineage cells (RBCs, granulocytes, megakaryocytes)
More informationManagement of anemia in CKD
Management of anemia in CKD Pierre Cochat, MD PhD Professor of Pediatrics Chair, Pediatrics & Pediatric Surgery Department Head, Center for Rare Renal Diseases Néphrogones Hospices Civils de Lyon & University
More informationChapter 2. ERYTHROPOIESIS and ANEMIA
Chapter 2 ERYTHROPOIESIS and ANEMIA Red Cell Production The Production of red cells, known as erythropoiesis, is a developmental system fundamentally under genetic control but modulated and regulated by
More informationM.Sc. III Semester Biotechnology End Semester Examination, 2013 Model Answer LBTM: 302 Advanced Immunology
Code : AS-2246 M.Sc. III Semester Biotechnology End Semester Examination, 2013 Model Answer LBTM: 302 Advanced Immunology A. Select one correct option for each of the following questions:- 2X10=10 1. (b)
More informationDone By : WESSEN ADNAN BUTHAINAH AL-MASAEED
Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED Acute Myeloid Leukemia Firstly we ll start with this introduction then enter the title of the lecture, so be ready and let s begin by the name of Allah : We
More informationCOORDINATION OF IRON AND OXYGEN SIGNALING THROUGH POST- TRANSCRIPTIONAL REGULATION OF HYPOXIA INDUCIBLE FACTOR-2ALPHA MCKALE R.
COORDINATION OF IRON AND OXYGEN SIGNALING THROUGH POST- TRANSCRIPTIONAL REGULATION OF HYPOXIA INDUCIBLE FACTOR-2ALPHA By MCKALE R. DAVIS Bachelor of Science in Nutrition and Dietetics Texas Christian University
More informationIn adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains
Thalassaemias Thalassemia Thalassemia is an inherited autosomal recessive blood disease. Associated with absence or reduction in a or b globin chains. Reduced synthesis of one of the globin chains can
More informationADx Bone Marrow Report. Patient Information Referring Physician Specimen Information
ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS
More informationYEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY
1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor
More informationERYTHROPOIESIS. Development of RBC s. 03-Dec-17. Before Birth (EMBRYO) Before Birth (EMBRYO) After Birth. MESOBLASTIC STAGE 1 st Trimester
Development of RBC s ERYTHROPOIESIS Before Birth (EMBRYO) Prof Dr Waqas Hameed HOD, Physiology Pak Int l Medical College After Birth Before Birth (EMBRYO) MESOBLASTIC STAGE 1 st Trimester Yolk Sac Capillary
More informationHosoya et al. TRIM28 is essential for erythroblast differentiation in the mouse (supplemental information)
TaqMan assay Gene TRIM28 GATA-1 Applied Biosystems TaqMan assay Mm00495594_m1 Mm01352636_m1 SYBR Green assay Gene Forward primer Reverse primer Reference adult α-globin CCCGGTGCCTTGTCTGCT GTGAAATCGGCAGGGTGG
More informationIron deficiency anemia and porphyrias
Iron deficiency anemia and porphyrias Fleur Wolff¹, Frédéric Cotton¹, Axelle Gilles² ¹Department of clinical chemistry, Hôpital Erasme, ULB ²Department of hematology, Hôpital Erasme, ULB BHS, November
More informationHASNA NADIA BT. HASAN SAZALLI JOSEPHIN SUZANA A/K JOHN ASIN LOW NORZUFIKAL BT. ZULKIFLY NURUL ALIYA BT ROSLAN MOHD SYAFFIQ BIN OTHMAN
HASNA NADIA BT. HASAN SAZALLI JOSEPHIN SUZANA A/K JOHN ASIN LOW NORZUFIKAL BT. ZULKIFLY NURUL ALIYA BT ROSLAN MOHD SYAFFIQ BIN OTHMAN Anatomy of Bone Marrow Syaffiq Othman Bone Marrow Bone marrow is a
More informationHematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte-macrophage colonystimulating factor (G-CSF).
Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte colony-stimulating factor(g-csf). Granulocyte-macrophage colonystimulating factor (G-CSF). Interleukin-11
More informationMyelodysplastic Syndromes Myeloproliferative Disorders
Myelodysplastic Syndromes Myeloproliferative Disorders Myelodysplastic Syndromes characterized by maturation defects that are associated with ineffective hematopoiesis and a high risk of transformation
More informationChronic Idiopathic Myelofibrosis (CIMF)
Chronic Idiopathic Myelofibrosis (CIMF) CIMF Synonyms Agnogenic myeloid metaplasia Myelosclerosis with myeloid metaplasia Chronic granulocytic-megakaryocytic myelosis CIMF Megakaryocytic proliferation
More informationMECHANISM AND MODE OF HORMONE ACTION. Some definitions. Receptor: Properties of receptors. PRESENTED BY MBUNKUR GLORY NKOSI.
MECHANISM AND MODE OF HORMONE ACTION. PRESENTED BY MBUNKUR GLORY NKOSI. OUTLINE. Introduction Some definitions Hormone secretion, transport, and clearance from the blood. Feedback control of hormone secretion.
More informationHEMATOPOIESIS. HEMATOLOGY Introduction. Study of blood & its components Window of rest of body. Introduction
HEMATOLOGY/ HEMATOPOIESIS Introduction HEMATOLOGY Introduction Study of blood & its components Window of rest of body 1 BLOOD Raison d etre Delivery of nutrients Oxygen Food Vitamins Removal of wastes
More informationChapter 19: The Cardiovascular System: The Blood. Copyright 2009, John Wiley & Sons, Inc.
Chapter 19: The Cardiovascular System: The Blood Blood Liquid connective tissue 1. Transportation - Gases, nutrients, hormones, and waste. 2. Regulation - ph, body temperature, and blood pressure. 3. Protection
More informationPreAssignment #14 The Endocrine and Cardiovascular Systems Name: Section #:
PreAssignment #14 The Endocrine and Cardiovascular Systems Name: Section #: 1) Label the names of the common endocrine glands indicated in this diagram. Then, list a few of the major hormones (if there
More informationHemolytic anemias (2 of 2)
Hemolytic anemias (2 of 2) Sickle Cell Anemia The most common familial hemolytic anemia in the world Sickle cell anemia is the prototypical (and most prevalent) hemoglobinopathy Mutation in the β-globin
More informationThe Cardiovascular System: Blood
C h a p t e r 11 The Cardiovascular System: Blood PowerPoint Lecture Slides prepared by Jason LaPres Lone Star College - North Harris Introduction to the Cardiovascular System A circulating transport system
More informationHEMATOLOGY/ HEMATOPOIESIS
HEMATOLOGY/ HEMATOPOIESIS Introduction HEMATOLOGY Introduction! Study of blood & its components! Window of rest of body 1 BLOOD Raison d etre! Delivery of nutrients!oxygen!food!vitamins! Removal of wastes!carbon
More informationLESSON 2: THE ADAPTIVE IMMUNITY
Introduction to immunology. LESSON 2: THE ADAPTIVE IMMUNITY Today we will get to know: The adaptive immunity T- and B-cells Antigens and their recognition How T-cells work 1 The adaptive immunity Unlike
More informationRama Nada. -Ensherah Mokheemer. 1 P a g e
- 3 - Rama Nada -Ensherah Mokheemer - 1 P a g e Don t forget to refer to page index wherever you see * Quick revision: In the previous lecture we said that: - your body contains 4-5g of iron (4g in females
More informationIron Overload Disorders and Iron Chelation Therapy
Iron Overload Disorders and Iron Chelation Therapy T. Lodewyck BHS seminar November 2014 Outline Iron overload (IO) disorders Mechanisms and pathophysiology of IO Clinical impact of IO Assessment of IO
More informationPrinciples of Anatomy and Physiology
Principles of Anatomy and Physiology 14 th Edition CHAPTER 19 The Cardiovascular System: The Blood Functions and Properties of Blood Blood is a liquid connective tissue consisting of cells surrounded by
More informationHereditary Hemochromatosis: What Have We Learnt from Population Studies Professor John K. Olynyk
Hereditary Hemochromatosis: What Have We Learnt from Population Studies School of Medicine & Pharmacology University of Western Australia & Department of Gastroenterology Fremantle Hospital 1 The amount
More informationWBCs Disorders 1. Dr. Nabila Hamdi MD, PhD
WBCs Disorders 1 Dr. Nabila Hamdi MD, PhD ILOs Compare and contrast ALL, AML, CLL, CML in terms of age distribution, cytogenetics, morphology, immunophenotyping, laboratory diagnosis clinical features
More informationThe T cell receptor for MHC-associated peptide antigens
1 The T cell receptor for MHC-associated peptide antigens T lymphocytes have a dual specificity: they recognize polymporphic residues of self MHC molecules, and they also recognize residues of peptide
More information7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour
7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic
More informationEFFECT OF DIETARY IRON DEFICIENCY AND OVERLOAD ON ZIP14 EXPRESSION IN RATS
EFFECT OF DIETARY IRON DEFICIENCY AND OVERLOAD ON ZIP14 EXPRESSION IN RATS By HYEYOUNG NAM A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS
More informationHEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY
HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEMATOCRIT Hematocrit is a measure of the percentage of the total blood volume that is made up by the red blood cells The hematocrit can be determined directly
More informationResearch and Development
SNP Frequencies in SLC11A2, HFE, TMPRSS6, and TF and their Association with the Indicators of Blood Iron Status and Concentration in Pregnant Filipino Women Vanessa Joy A. Timoteo a, Jacus S. Nacis a,
More informationTreatment of low risk MDS
Treatment of low risk MDS Matteo G Della Porta Cancer Center IRCCS Humanitas Research Hospital & Humanitas University Rozzano Milano, Italy matteo.della_porta@hunimed.eu International Prognostic Scoring
More informationMECHANISMS OF NON-TRANSFERRIN-BOUND IRON UPTAKE BY HUMAN β CELLS AND THE ROLE OF IRON IN DIABETIC PATHOGENESIS
MECHANISMS OF NON-TRANSFERRIN-BOUND IRON UPTAKE BY HUMAN β CELLS AND THE ROLE OF IRON IN DIABETIC PATHOGENESIS By RICHARD COFFEY A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA
More informationStem cells: units of development and regeneration. Fernando D. Camargo Ph.D. Whitehead Fellow Whitehead Institute for Biomedical Research.
Stem cells: units of development and regeneration Fernando D. Camargo Ph.D. Whitehead Fellow Whitehead Institute for Biomedical Research Concepts 1. Embryonic vs. adult stem cells 2. Hematopoietic stem
More informationMyelodysplastic Syndromes: Everyday Challenges and Pitfalls
Myelodysplastic Syndromes: Everyday Challenges and Pitfalls Kathryn Foucar, MD kfoucar@salud.unm.edu Henry Moon lecture May 2007 Outline Definition Conceptual overview; pathophysiologic mechanisms Incidence,
More informationThalassemia Maria Luz Uy del Rosario, M.D.
Thalassemia Maria Luz Uy del Rosario, M.D. Philippine Society of Hematology and Blood Transfusion Philippine Society of Pediatric Oncology What is Thalassemia Hereditary Hemoglobin disorder Hemolytic anemia
More informationSerum soluble transferrin receptor in hypochromic microcytic anaemia
O r i g i n a l A r t i c l e Singapore Med Med J 2006; J 2006; 47(2) 47(2) : 138 : 1 Serum soluble transferrin receptor in hypochromic microcytic anaemia Jayaranee S, Sthaneshwar P ABSTRACT Introduction:
More informationCynthia Fata, MD, MSPH 6/23/15
Cynthia Fata, MD, MSPH 6/23/15 Clinical case presentation Introduction to thrombopoietin Development of thrombopoietic agents Clinical Indications Eltrombopag use in aplastic anemia Future uses 33 yo F
More informationThe Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.
Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia The Harvard community
More informationRed cell disorder. Dr. Ahmed Hasan
Red cell disorder Dr. Ahmed Hasan Things to be learned in this lecture Definition and clinical feature of anemia. Classification of anemia. Know some details of microcytic anemia Question of the lecture:
More informationINTERELATIONSHIP BETWEEN IDA AND VITAMIN D DEFICIENCY IS NOW ESTABLISHED
INTERELATIONSHIP BETWEEN IDA AND VITAMIN D DEFICIENCY IS NOW ESTABLISHED Rationale for Combining Iron & Vit-D Vit D deficiency and Iron deficiency Anaemia the two most menacing disorders - are inter-related
More informationAplastic Anemia: Understanding your Disease and Treatment Options
Aplastic Anemia: Understanding your Disease and Treatment Options No financial relationships or commercial interest related to the content of this presentation Josh Sasine, MD, PhD Hematopoietic Cell Transplant
More informationEffective Health Care Program
Comparative Effectiveness Review Number 83 Effective Health Care Program Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease Executive Summary Background Chronic
More informationDefensive mechanisms include :
Acquired Immunity Defensive mechanisms include : 1) Innate immunity (Natural or Non specific) 2) Acquired immunity (Adaptive or Specific) Cell-mediated immunity Humoral immunity Two mechanisms 1) Humoral
More informationPNH Glossary of Terms
AA Absolute neutrophil count Alendronate Allergen ALT Anemia Antibodies Anticoagulant Anticoagulation Antigen Antithymocyte globulin (ATG) Aplastic Aplastic anemia Band Bilirubin Blast cells Bone marrow
More informationIron Deprivation in Cancer-Potential Therapeutic Implications
Iron Deprivation in Cancer-Potential Therapeutic Implications Jessical L. Heath, Duke University Joshua M. Weiss, Duke University Catherine P. Lavau, Duke University Daniel Wechsler, Emory University Journal
More informationPATHOLOGY OF THE HEMATOLYMPHOID SYSTEM 1 AND 2 -INTRODUCTION TO ANEMIA - ANEMIA OF DECREASED PRODUCTION.
PATHOLOGY OF THE HEMATOLYMPHOID SYSTEM 1 AND 2 -INTRODUCTION TO ANEMIA - ANEMIA OF DECREASED PRODUCTION. 1 ANEMIA Anemia is defined as decrease in the RBC mass, it usually is reflected by decrease in hemoglobin
More informationAplastic anamia & Sideroblastic anemia
Hematology Lecture 7 كلية التقنيات الصحية والطبية قسم التحليالت المرضية Aplastic anamia & Sideroblastic anemia اإلعداد: ظفر جبار دهاق فؤاد APLASTIC ANEMIA What is Aplastic anemia? Aplastic anemia is a
More informationCongenital Dyserythropoietic anemias: where we are
Congenital Dyserythropoietic anemias: where we are Achille Iolascon Department of Molecular Medicine and Medical Biotechnology University Federico II of Naples, Italy achille.iolascon@unina.it 6 th EUROPEAN
More informationErythrocytes. Dr. MOHAMED SAAD DAOUD BCH 471 1
Red blood cells Erythrocytes Circulating erythrocytes are derived from erythropoietic cells (the precursors of erythrocytes). RBCs arise from mesenchymal cells present in bone marrow. RBCs lack nucleus
More informationHematopoiesis. BHS Liège 27/1/2012. Dr Sonet Anne UCL Mont-Godinne
Hematopoiesis BHS Liège 27/1/2012 Dr Sonet Anne UCL Mont-Godinne Hematopoiesis: definition = all the phenomenons to produce blood cells Leukocytes = White Blood Cells Polynuclear = Granulocytes Platelet
More informationIron deficiency anemia:
بسم هللا الرمحن الرحمي Before we start: Dr. Malik suggested for the third immunity lecture to be a continuation for the hematology pharmacology. And he will discuss the drugs for treating leukemia and
More information